PPARA and metabolic dysfunction-associated steatotic liver disease: Taken together, our data demonstrate that hepatocyte-specific deletion of Pparα promotes steatosis and inflammation in HFD-induced obesity and provide further pre-clinical evidence that hepatocyte PPARα is a relevant direct target in NAFLD.